Defining resistance mechanisms to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

ANNALS OF ONCOLOGY

ELSEVIER

1. National Health and Medical Research Council (NHMRC) Investigator grant